ProQR Therapeutics N.V. Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -0.54M-4.32M-16.12M-23.14M-43.29M-49.32M-43.81M-63.55M-53.22M-71.95M-65.50M-30.00M-29.67M
Depreciation and Depletion 0.03M0.17M0.53M1.38M1.17M2.30M2.69M2.76M2.57M2.72M2.95M
Share-based Compensation 1.35M2.72M4.54M6.39M10.20M8.95M7.36M2.93M3.36M2.72M
Gains from Investment Securities -2.26-1.18-0.07M0.10M-2.22M
Change in Working Capital 0.12M1.10M1.45M-0.71M-1.59M-0.19M-1.53M-1.90M6.25M-29.60M-0.45M-52.96M
Change in Taxes 0.00M-0.00M0.15M0.14M0.14M0.10M-0.08M-0.21M
Cash from Operations -0.42M-3.10M-19.22M-26.92M-37.88M-39.47M-33.66M-49.24M-53.73M-30.78M-69.90M23.31M-41.75M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 0.03M0.17M0.53M1.38M1.20M1.17M2.30M2.69M2.76M2.57M2.72M2.95M
Investing Activities
Capital Expenditures 1.44M2.81M0.14M0.37M0.65M1.05M0.57M0.72M1.48M1.52M
Sales of Property, Plant and Equipment 0.07M0.01M0.06M
Cash from Investing Activities -0.05M-0.18M-1.64M-1.47M-2.81M-0.14M-0.37M-0.65M-1.05M-0.50M-0.72M4.63M-4.35M
Financing Activities
Cash from Financing Activities 0.79M8.43M159.36M1.80M0.40M30.09M102.13M56.22M16.56M161.93M-31.52M-2.46M75.10M
Debt Issuance and Repayment
Non-Current Debt 201.18M
Net Debt Issuances and Repayments 201.18M
Change in Capital Stock
Net Equity Issued and Repurchased 0.67M4.01M157.19M54.37M128.37M
Additional items
Exchange Rate Effect 5.87M6.74M0.82M-3.01M-0.20M0.81M-3.00M1.53M7.50M0.65M0.72M
Change in Cash 0.32M5.15M138.50M-26.59M-40.30M-9.52M68.11M6.33M-38.23M130.64M-102.13M25.48M31.85M
Beginning Cash Balance -0.32M-5.15M-138.50M26.59M40.30M9.52M-68.11M-6.33M38.23M91.27M198.82M103.17M127.80M
Free Cash Flow -0.42M-3.10M-19.22M-28.36M-40.70M-39.61M-34.03M-49.89M-54.79M-31.36M-70.62M21.83M-43.27M
Net Cash Flow 0.32M5.15M138.50M-26.59M-40.30M-9.52M68.11M6.33M-38.23M130.64M-102.13M25.48M28.99M